StockData
Senti Biosciences Holdings, Inc. logo

Senti Biosciences Holdings, Inc. (SNTI) stock

SNTINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 4/30
$0.10−0.04 (-28.68%)

Close on Nov 17, 2026Market cap $3.02MP/E –Yield –

Senti Biosciences operating margin

Operating margin is operating income as a percentage of revenue.

Senti Biosciences's operating margin for the twelve months ending Jun 30, 2024 was -27287.3%. For fiscal 2025 it was -312631.8%, against -3620.7% the year before.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-312631.8%−309011.1
FY2023Dec 31, 2023-3620.7%−2172.2
FY2022Dec 31, 2022-1448.5%+16.4
FY2021Dec 31, 2021-1464.9%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026-85229.4%−84065.8
Q1 FY2026Mar 31, 2026-28850.0%−385.6
Q3 FY2023Sep 30, 2023-12981.1%−12146.0
Q2 FY2023Jun 30, 2023-1620.9%−17.8
Q1 FY2023Mar 31, 2023-1163.6%−98.6
Q4 FY2022Dec 31, 2022-28464.4%−27091.8
Q3 FY2022Sep 30, 2022-835.1%+200.5
Q2 FY2022Jun 30, 2022-1603.2%−468.7
Q1 FY2022Mar 31, 2022-1065.0%–
Q4 FY2021Dec 31, 2021-1372.6%–
Q3 FY2021Sep 30, 2021-1035.6%–
Q2 FY2021Jun 30, 2021-1134.4%–

More Senti Biosciences figures

See a number that looks wrong?